GALANTAMINE/TU - Search Results

Year	Number of Results
1965	3
1966	2
1967	8
1968	5
1969	3
1970	3
1971	3
1972	4
1973	2
1974	3
1976	4
1977	1
1978	3
1979	1
1985	2
1986	2
1987	2
1988	2
1990	2
1991	2
1992	1
1993	1
1994	1
1996	4
1997	1
1998	1
1999	2
2000	14
2001	36
2002	41
2003	37
2004	53
2005	44
2006	64
2007	53
2008	58
2009	46
2010	37
2011	42
2012	25
2013	21
2014	30
2015	27
2016	23
2017	21
2018	13
2019	12
2020	14
2021	19
2022	25
2023	14
2024	17
2025	13
2026	7

1

Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease.

Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F. Marucci G, et al. Neuropharmacology. 2021 Jun 1;190:108352. doi: 10.1016/j.neuropharm.2020.108352. Epub 2020 Oct 6. Neuropharmacology. 2021. PMID: 33035532 Free article. Review.

2

Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.

Lim AWY, Schneider L, Loy C. Lim AWY, et al. Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4. Cochrane Database Syst Rev. 2024. PMID: 39498781 Free PMC article.

3

Alzheimer's disease.

Blennow K, de Leon MJ, Zetterberg H. Blennow K, et al. Lancet. 2006 Jul 29;368(9533):387-403. doi: 10.1016/S0140-6736(06)69113-7. Lancet. 2006. PMID: 16876668 Review.

4

Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice.

Liu Y, Zhang Y, Zheng X, Fang T, Yang X, Luo X, Guo A, Newell KA, Huang XF, Yu Y. Liu Y, et al. J Neuroinflammation. 2018 Apr 18;15(1):112. doi: 10.1186/s12974-018-1141-5. J Neuroinflammation. 2018. PMID: 29669582 Free PMC article.

5

Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.

Hansen RA, Gartlehner G, Webb AP, Morgan LC, Moore CG, Jonas DE. Hansen RA, et al. Clin Interv Aging. 2008;3(2):211-25. Clin Interv Aging. 2008. PMID: 18686744 Free PMC article.

6

Evaluating the efficacy and safety of Alzheimer's disease drugs: A meta-analysis and systematic review.

Chen Y, Lai M, Tao M. Chen Y, et al. Medicine (Baltimore). 2024 Apr 19;103(16):e37799. doi: 10.1097/MD.0000000000037799. Medicine (Baltimore). 2024. PMID: 38640313 Free PMC article.

7

Cholinesterase inhibitors for Alzheimer's disease.

Birks J. Birks J. Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD005593. doi: 10.1002/14651858.CD005593. Cochrane Database Syst Rev. 2006. PMID: 16437532 Free PMC article.

8

Galantamine ameliorates experimental pancreatitis.

Thompson DA, Tsaava T, Rishi A, George SJ, Hepler TD, Hide D, Pavlov VA, Brines M, Chavan SS, Tracey KJ. Thompson DA, et al. Mol Med. 2023 Oct 31;29(1):149. doi: 10.1186/s10020-023-00746-y. Mol Med. 2023. PMID: 37907853 Free PMC article.

9

Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.

Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Chougule MB, Shoyele SA, Alexander A. Agrawal M, et al. J Control Release. 2018 Jul 10;281:139-177. doi: 10.1016/j.jconrel.2018.05.011. Epub 2018 May 24. J Control Release. 2018. PMID: 29772289 Review.

10

Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer's disease: A systematic review and meta-analysis.

Gao Y, Liu Y, Li Y. Gao Y, et al. Adv Clin Exp Med. 2024 Nov;33(11):1179-1187. doi: 10.17219/acem/176051. Adv Clin Exp Med. 2024. PMID: 38439609 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

813 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

813 results

Results by year